Tradestie Institutional Equity Comparison Engine

CCCC vs OKYO โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

OKYO Overall Edge

OKYO Captures Institutional Edge (2โ€“1 Pillars ยท 3โ€“5 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to OKYO Pharma Limited Ordinary Shares (OKYO) driven by superior Growth & Margin, Options & Structure while CCCC counters with relative strength in Momentum & Technical. Fundamentally, CCCC trades at N/M Forward P/E with -315.9% operating margin (-24.6% YoY revenue) versus OKYO at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, CCCC sits in BREAKDOWN (3rd %ile IV; Dealer Gamma Walls on Pro) against OKYO sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
CCCC N/M vs OKYO N/M Fwd P/E
Growth & Margin Winner OKYO
Op Margin -315.9% vs 0.0% ยท YoY -24.6% vs +0.0%
Momentum & Technical Winner CCCC
1Y -0.8% vs -47.0% ยท 52W Pos 23% vs 3%
Options & Structure Winner OKYO
BREAKDOWN (3rd %ile IV) vs UNCLASSIFIED (N/A IV)
CCCC NASDAQ
C4 Therapeutics, Inc.
Biological Products, (No Disgnostic Substances)
$2.48
+1.64% 1D
Market Cap $325.7M
1M Return -22.01%
1Y Return -0.8%
Forward P/E N/M
Unified AI Score
57.7 / 100 HOLD
Tech 58.0 Fund 60.0 Flow 64.0 Mom 60.0
OKYO NASDAQ
OKYO Pharma Limited Ordinary Shares
Biological Products, (No Diagnostic Substances)
$1.07
-7.76% 1D
Market Cap $62.7M
1M Return -27.21%
1Y Return -47.03%
Forward P/E N/M
Unified AI Score
42.8 / 100 HOLD
Tech 38.0 Fund 54.0 Flow 50.0 Mom 45.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: CCCC -0.8% OKYO -47.03% Spread: +46.23 pp (CCCC Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
CCCC TTM Op. Margin: -315.9% OKYO TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on CCCC vs OKYO. Trailing 12-month operating profitability (CCCC -315.9% vs OKYO 0.0%) and valuation multiples (CCCC N/M vs OKYO N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: CCCC (5) vs OKYO (3)
Institutional Metric CCCC OKYO Criterion Row Winner
Market Capitalization Scale $325.7M $62.7M Larger Scale CCCC
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth -24.6% +0.0% Higher Growth OKYO
Operating Margin (TTM) Profitability -315.9% 0.0% Higher Margin OKYO
Net Profit Margin Profitability -282.2% 0.0% Higher Margin OKYO
Return on Equity (ROE) Capital Efficiency -47.6% -263.8% Higher ROE CCCC
52-Week Range Position Momentum 23% ($2โ€“$5) 3% ($1โ€“$3) Stronger Trend CCCC
Beta / 30D Volatility Risk Regime 1.25ฮฒ ยท 60% Vol 1.00ฮฒ ยท 76% Vol Lower Realized Risk CCCC
Unified Institutional Score Composite Signal 57.7 / 100 (HOLD) 42.8 / 100 (HOLD) Higher Composite CCCC

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full CCCC vs OKYO Buy Guide
CCCC BREAKDOWN
121d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 3rd %ile
IV Regime Compressed (<25th %ile)
Live CCCC Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
OKYO UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live OKYO Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither CCCC nor OKYO registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.